Thomas Schatton

Thomas Schatton is a seasoned professional with extensive experience in leadership roles across various industries. Currently serving as Gesellschafter at savvytec since March 2022 and as CEO of Four 20 Pharma GmbH since January 2021, Thomas has demonstrated strong management skills. Previously, Thomas held the position of Geschäftsführender Gesellschafter at W-AYS GmbH & Co. KG from December 2012 to March 2022, contributing to the strategic direction and operational success of the company.